Infection Surveillance Solutions Market

Global Infection Surveillance Solutions Market Size (2023 to 2028)

The global infection surveillance solutions market size is estimated to be worth USD 1231 million by 2028 from USD 643.1 million in 2023, growing at a CAGR of 13.88% from 2023 to 2028.

Global Infection Surveillance Solutions Market Share Insights:

• Based on product and service, the software segment had the major share of the global market in 2022.
• Based on infection, the urinary tract infections (UTI) segment held the leading share of the worldwide market in 2022.
• Based on end-user, the hospitals segment accounted for the largest share of the global market in 2022.
• Based on region, North America dominated the market in 2022.

Impact of COVID-19 on the global infection surveillance solutions market:

The COVID-19 pandemic has had a significant impact on the market for Infection surveillance solutions. Due to the rapid spread of the COVID-19 virus, effective surveillance and monitoring have become crucial for containing the outbreak. The demand for infection surveillance solutions has increased, with healthcare providers and governments seeking advanced technology to detect, prevent and manage infections in healthcare facilities. The adoption of advanced surveillance solutions, such as electronic medical records, digital surveillance systems, and automated alerts has increased significantly in the recent past. As healthcare providers attempt to prepare for future outbreaks, it is anticipated that demand for these solutions will continue to rise in the post-pandemic era. However, the market has also encountered difficulties because of disruptions in global supply chains, a lack of essential medical supplies, and a decline in international tourism.

MARKET DRIVERS:

The growing prevalence of HAIs is one of the major factors propelling the infection surveillance solutions market growth. HAIs also known as hospital-acquired infections are a significant source of worry for medical professionals all over the globe. Infections caused by HAIs may result in increased morbidity and death rates, as well as longer hospital stays and more medical expenses. As the incidence of HAIs continues to rise, there has been an increased need for infection monitoring solutions among healthcare professionals who are working to establish efficient infection control and prevention procedures.

The rapid adoption of innovative surveillance technologies further contributes to the market growth. The development of sophisticated surveillance solutions, such as digital surveillance systems, electronic medical records and automated warnings resulted in the effective management of infection control and realizing the importance of such technological solutions; several governments and end-users have been using these for their needs. These systems allow medical professionals to monitor patient data in real time, enabling them to see the beginnings of possible epidemics and react quickly enough to stop the spread of illnesses.

The rising emphasis on patient safety and infection control in healthcare facilities, stringent government regulations and policies promoting infection surveillance and reporting, growing awareness among healthcare providers about the importance of infection surveillance in reducing healthcare costs and improving patient outcomes and technological advancements enabling real-time monitoring and analysis of infection data boost the growth rate of the infection surveillance solutions market. The rapid adoption of electronic health records (EHRs) and healthcare information systems, facilitating data collection and analysis for infection surveillance, rising demand for cloud-based infection surveillance solutions for easy access, scalability, and data security and collaborations and partnerships between healthcare organizations and infection surveillance solution providers to develop comprehensive and integrated systems propel the market growth.

MARKET RESTRAINTS:

Poor awareness and understanding among healthcare providers about the benefits and importance of infection surveillance solutions, budget constraints and limited financial resources for healthcare facilities and resistance to change and reluctance to adopt new technologies and processes in traditional healthcare settings majorly hamper the growth of the infection surveillance solutions market. Complexity and interoperability challenges in integrating infection surveillance solutions with existing healthcare IT systems, data privacy and security concerns related to the collection, storage, and sharing of sensitive patient information and limited standardization and variability in infection surveillance practices across different healthcare facilities and regions further impede the market growth.

REPORT COVERAGE:

This research report on the global infection surveillance solutions market has been segmented and sub-segmented based on product and service, infection type, end-user, and region.

Infection Surveillance Solutions Market - By Product and Services:

• Software
  • On-premises
  • Web-based
• Services

Based on products and services, the software segment is expected to account for the major share of the worldwide market during the forecast period. Factors such as technological advancements, addressing the burden of HAIs, regulatory compliance, real-time monitoring capabilities, resource optimization and demand for integrated infection surveillance systems majorly drive the growth of the software segment in the infection surveillance solutions market. The on-premises sub-segment had the major share of the global market in 2022 and the domination is likely to continue during the forecast period.

On the other hand, the services segment is anticipated to witness the highest CAGR during the forecast period and hold a considerable share of the worldwide market. The growing complexity and technical requirements of infection surveillance systems that necessitate specialized services such as consulting, data management, and technical support are one of the key factors propelling the segmental growth. The growing recognition of the importance of training and education to ensure effective utilization of infection surveillance solutions and the increasing need for ongoing support, updates, and customization options to align the surveillance systems with evolving healthcare needs and regulations further boost the growth of the services segment in the worldwide market.

Infection Surveillance Solutions Market - By Infection:

• Surgical Site Infections (SSI)      
• Blood Stream Infections (BSI)
• Urinary Tract Infections (UTI)
• Others

Based on infection, the urinary tract infections (UTI) segment is expected to capture the leading share of the worldwide market during the forecast period owing to the high prevalence of UTIs, their impact on patient outcomes and healthcare costs, and the focus on infection prevention and control. The growing demand for proactive surveillance to promptly identify, monitor, and manage UTIs further boost the growth rate of the UTI segment in the global market.

Infection Surveillance Solutions Market -By End-use:

• Long-Term Care Facilities
• Hospitals
• Clinic
• Ambulatory Surgical Centers

Based on end-user, the hospital segment is expected to hold the leading share of the worldwide market during the forecast period. The growing focus on patient safety and infection control in hospitals, stringent regulations and accreditation requirements that emphasize infection prevention and monitoring in healthcare settings and the increasing need for real-time monitoring, reporting, and intervention to reduce healthcare-associated infections and improve patient outcomes primarily drive the growth of the hospital segment in the worldwide market.

The long-term care facilities segment is anticipated to capture a considerable share of the worldwide market during the forecast period. The growing aging population and the higher risk of infections in long-term care settings, regulatory guidelines and quality measures specific to long-term care facilities that emphasize infection prevention and surveillance and rising focus on improving resident safety and quality of care drive the growth of the long-term care facilities segment.

Infection Surveillance Solutions Market – By Region:

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

North America dominated the infection surveillance solutions market in 2022 and the domination of the North American market is anticipated to continue throughout the forecast period. Stringent regulatory guidelines and accreditation requirements promoting infection prevention and surveillance in healthcare facilities are one of the major factors propelling the North American market. Technological advancements and widespread adoption of electronic health records (EHRs) facilitating data collection and analysis and rising focus on patient safety and quality improvement initiatives further boost the growth rate of the North American market. The U.S. had the largest share of the North American market in 2022 and the lead of the U.S. market is expected to continue during the forecast period owing to the high healthcare spending and advanced healthcare systems and rapid adoption of advanced technologies, such as AI and machine learning.

Europe is a prominent regional market for infection surveillance solutions worldwide and is anticipated to account for a substantial share of the global market during the forecast period. Strict regulations and guidelines promoting infection prevention, control, and surveillance in healthcare facilities, rising awareness about healthcare-associated infections (HAIs) and their impact on patient outcomes and growing emphasis on reducing healthcare costs and improving efficiency through proactive infection surveillance majorly propel the European market growth. The United Kingdom, Germany, and France are anticipated to account for the major share of the European market during the forecast period owing to the rapid adoption of advanced analytics and integration of infection surveillance with existing healthcare systems.

APAC is the most lucrative regional market for infection surveillance solutions and is estimated to register the fastest CAGR during the forecast period. Factors such as the growing healthcare infrastructure and rising investments in healthcare facilities, rising awareness about infection prevention and control, high burden of HAIs and technological advancements and digital transformation initiatives in healthcare drive the growth of the APAC market. China and India are predicted to hold the leading share of the APAC market during the forecast period due to their large populations, increasing number of healthcare capabilities and rapid adoption of cloud-based solutions and telehealth technologies.

KEY MARKET PLAYERS:

Cerner Corporation, Epic Systems Corporation, Truven Health Analytics, Premier, Inc., RL Solutions, Becton, Dickinson and Company (BD), Wolters Kluwer N.V., VigiLanz Corporation, Baxter International Inc. and RLDatix are some of the major companies in the worldwide infection surveillance solutions market.

RECENT HAPPENINGS IN THE MARKET:

• Delphi Corporation launched a new platform called Delphi Infectious Disease Intelligence (DIDI) in March 2021. This platform uses artificial intelligence (AI) to monitor and predict the spread of infectious diseases, such as COVID-19.
• Baxter International Inc. announced a partnership with bioMérieux in January 2021 to develop a new hospital-acquired infection surveillance solution.